A pharmacogenomic approach validates AG-221 as an... : Leukemia (original) (raw)

Button group.

LETTERS TO THE EDITOR

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML

• L M Kats
• S J Vervoort
• R Cole
• A J Rogers
• G P Gregory
• E Vidacs
• J Li
• R Nagaraja
• K E Yen
• R W Johnstone

Leukemia

31

(

6

)

:p

1466

-

1470

,

June 2017

.

| DOI: 10.1038/leu.2017.84

Copyright © 2017 Nature Publishing Group